Such-Lupe

Shareholders' Meeting resolution of June 25, 2002

Authorization of the Executive Board to create authorized capital and to amend the company's articles of association accordingly.

Resolution of the Shareholders' Meeting to create new authorized capital in the amount of 24,336,000.00 EUR by amending § 6 (1) of the articles of association as follows;

"The Executive Board is authorized, with the consent of the Supervisory Board, to raise the share capital of the Company on or before June 24, 2007 on one or more occasions by up to 24,336,000.00 EUR through the issue of up to 9,360,000 registered shares of limited transferability against cash contributions. Shareholders are to be granted a subscription right, with the exception of the following cases: (a) residual fractional amounts; (b) on one or more occasions up to a total of 1,872,392 shares, if a market price has been established and the issue price is not substantially below the market price. Treasury shares that have been sold since June 25, 2002 under the provisions of § 186 (3) sentence 4 of the German Stock Corporation Act (AktG) are to be included in the calculation of the maximum number of shares pursuant to (b)."

Click here for further details!

Here we have provided you with an overview of important facts and information from strategy through business segments, sales networks and the history of STADA Arzneimittel AG. More
The management of STADA Arzneimittel AG introduce themselves! Here you will find the members of the Executive Board, the Supervisory Board and the Advisory Board. More
Here you will find corporate news and ad-hoc releases that you can read directly on your screen or download as a PDF file. Older releases are available for you in our archive. More
Notices in accordance with the German Securities Trading Act (WpHG) as well as the annual document and the annual financial statements of STADA Arzneimittel AG can be viewed here. More

 

(c) 2012 STADA Arzneimittel AG, Stadastraße 2-18, 61118 Bad Vilbel, Telefon 06101 603-0, Fax 06101 603-259, e-Mail: info@stada.de